Back to results
US 7,008,926 B2Granted
Blood coagulation factor XIII for treating platelet disorders
AssigneeZymoGenetics, Inc.
InventorPaul D. Bishop
Life of this patent
Estimating the term…
Abstract
Use of factor XIII for treating the symptoms of thrombocytopenia. A patient having thrombocytopenia, either chemically- or metabolically induced, is treated by administering factor XIII.
Claims7
A method for treating chemically-induced or metabolically induced thrombocytopenia in an individual comprising administering to the individual a therapeutically effective amount of factor XIII.
A method for treating platelet dysfunction in an individual comprising administering to the individual a therapeutically effective amount of factor XIII.
Dependencies are inferred from the claim text.